Approval · Notice of Compliance 26580 · 2021
NATESTO: Notice of Compliance 26580
Issued September 1, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26580
- Date
- September 1, 2021
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To provide changes to the design of the Inner and Outer labels.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NATESTO | Not yet assigned | — |
Medicinal ingredients
- TESTOSTERONE 4.5 PER